Comparative evidence rests on one clinically selected, non-randomized cohort in which no difference was statistically detectable; this establishes neither equivalence nor absence of harm.
Abstract
Lung transplantation is conventionally performed through clamshell thoracosternotomy or sternotomy, approaches associated with pain, impaired wound healing, and chronic neuralgia. Robotic assistance has reached transplantation only recently. We systematically reviewed the clinical experience with robotic-assisted lung transplantation. Following PRISMA 2020 and PRISMA-S, we searched MEDLINE, Embase, Scopus, Web of Science, and Cochrane CENTRAL from inception to 15 August 2026, with trial registries, conference abstracts, and Chinese-language sources, without language restriction. Human robotic lung transplant reports with at least one clinical outcome were eligible. Because only one comparative cohort existed, synthesis was narrative; no meta-analysis was performed. Certainty was graded by outcome. PROSPERO: CRD420261479535. Out of 393 database records and 7 from other methods, six reports from five reporting centers (27 unique recipients) were included. No randomized trial or prior full-length systematic review was identified. In the only comparative cohort (robotic n = 21 vs. direct-vision minimally invasive n = 90), one-year survival was 95.0% versus 95.5% (log-rank P = 0.84) and grade-3 primary graft dysfunction at 72 h 4.8% versus 8.9% (odds ratio 0.51, 95% CI 0.06–4.34), despite longer ischemic times (486 vs. 408 min; P = 0.02). Every robotic versus direct-vision confidence interval included unity. Certainty was very low for all outcomes. Robotic lung transplantation is technically feasible across five reporting centers. Comparative evidence rests on one clinically selected, non-randomized cohort in which no difference was statistically detectable; this establishes neither equivalence nor absence of harm. Multicenter prospective evaluation with standardized outcomes is required. Registration: The protocol was registered with PROSPERO (CRD420261479535).
Early institutional experience suggests SP-RAKT is technically feasible in carefully selected patients at experienced centers, with minimal blood loss, short hospitalization, and early graft function consistent with established benchmarks, which support feasibility but not comparative safety or superiority over open or...
Pierangelo Nitzkowski, Aaron Ouyang, Thriaksh Rajan et al.· International Urology and Ne...· 0 citations
Background
Minimally invasive liver surgery (MILS) has progressively evolved from minor resections to technically demanding major hepatectomies. While laparoscopic hepatectomy is now widely established, robotic platforms have emerged as a promising alternative, potentially overcoming the ergonomic and technical limitat...
Background Robotic-assisted minimally invasive esophagectomy (RAMIE) is a significant evolution in esophageal cancer surgery, providing improved visualization, dexterity and operative precision. However, RAMIE is technically demanding and has a steep learning curve. The goal of this systematic review was to assess the...
Konstantinos Kossenas, A. Mylonakis, D. Avgerinos et al.· Frontiers in Oncology· 0 citations
Recovery-centered outcomes across surgical specialties are synthesized, suggesting length of stay and operative duration are procedure- and care-pathway-dependent outcomes, and Frailty, comorbidity, surgical complexity and team experience are essential to interpretation.
Lin Wang, Cheng-Lu Ruan· Journal of Robotic Surgery· 0 citations
Kidney transplantation relocates a vascularized graft and ureter into the iliac fossa, changing subsequent urologic surgery. Existing syntheses are procedure-specific. This scoping review mapped indications, graft-protection strategies, outcomes, and evidence gaps across robot-assisted urologic operations after kidney...
R. B. Drobot, Jacek Chełchowski, Artur Stępień et al.· Journal of Robotic Surgery· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.